A team of researchers from the University of Barcelona and the Bellvitge Biomedical Research Institute (IDIBELL) has ...

There’s still a lot we don’t know about how Parkinson’s disease develops. But one lifestyle intervention already has strong evidence behind it.

Analysis suggests that the research and development of DMTs and non-motor therapies will diversify Parkinson's treatment ...

Does inhibiting TMEM16F actually reduce the symptoms of Parkinson's disease? Does the lipid composition of cell membranes ...

Two recent chemistry studies pinpoint reactions that may link the gut microbiome to the development of Parkinson's disease.

In addition, they often have milder symptoms, especially in the early stages ... could be a promising candidate diagnostic ...

A team of researchers from the University of Barcelona and the Bellvitge Biomedical Research Institute (IDIBELL) has identified a potential biomarker of Parkinson's disease progression.

Subscribe to Here’s the Deal, our politics newsletter for analysis you won’t find anywhere else.

The following column was originally published on Feb. 25, 2022. Thanks to breakthroughs in medicine and nutrition in recent years, we are living longer than ever before. But this increase in life ...

Israeli scientists have identified a promising new factor in the pathology of Parkinson’s disease that could pave the way for ...

While Parkinson’s disease (PD) has a large and highly generalised therapeutic ... and therapies addressing non-motor symptoms ...

The Parkinson’s disease (PD) therapeutic landscape is heavily genericized, leaving substantial unmet needs in neuroprotective ...